Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

NCT02995772 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

122

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Aromatase Inhibitors (Arimidex)
DRUG: Tamoxifen
PROCEDURE: SOB
DRUG: FAC
DRUG: Aromatase Inhibitors (Femara)
DRUG: Aromatase Inhibitors (Aromasin)

Sponsor

Dharmais National Cancer Center Hospital